Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board  >  La Jolla Pharmaceutical Company    LJPCD

SummaryQuotesNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

LA JOLLA PHARMACEUTICAL COMPANY : REVERSE SPLIT: 1 of 50

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/14/2014 CET
A split is applied today to La Jolla Pharmaceutical Company's stock price.


© Factset 2014
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LA JOLLA PHARMACEUTICAL CO
11/10 LA JOLLA PHARMACEUTICAL COMPANY : Announces Financial Results for the Three and ..
11/09 LA JOLLA PHARMACEUTICAL CO : Results of Operations and Financial Condition, Fina..
11/04 LA JOLLA PHARMACEUTICAL COMPANY : Announces Financial Results for the Three and ..
11/03 LA JOLLA PHARMACEUTICAL : posts 3Q loss
11/03 LA JOLLA PHARMACEUTICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL COND..
11/03 LA JOLLA PHARMACEUTICAL COMPANY : Announces Financial Results for the Three and ..
10/24 LA JOLLA PHARMACEUTICAL COMPANY : Receives Positive Opinion from European Orphan..
10/13 LA JOLLA PHARMACEUTICAL : Patent Issued for Compositions and Methods for Treatin..
09/19 LA JOLLA PHARMACEUTICAL CO : Other Events, Financial Statements and Exhibits (fo..
09/08 LA JOLLA PHARMACEUTICAL CO : Other Events, Financial Statements and Exhibits (fo..
More news
Sector news : Bio Therapeutic Drugs
12/03DJJOHNSON & JOHNSON : Boosts Actelion Bid -Bloomberg
12/02 Pharma execs weigh in on possible changes under Trump
11/30 ACTELION : Rejecting J&J could leave Actelion with 'lot of explaining to do'
11/28 Actelion's ambitious independent-minded CEO will drive up takeover price
11/26DJWHAT'S NEWS : Business & Finance -- WSJ
More sector news : Bio Therapeutic Drugs
Advertisement
Financials ($)
Sales 2016 1,66 M
EBIT 2016 -74,5 M
Net income 2016 -74,4 M
Debt 2016 -
Yield 2016 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 204x
Capi. / Sales 2017 942x
Capitalization 338 M
More Financials
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 43,4 $
Spread / Average Target 134%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
George Francis Tidmarsh President, CEO, Secretary & Director
Kevin C. Tang Chairman
Jennifer Carver Senior Vice President-Operations
Dennis M. Mulroy Chief Financial & Accounting Officer
James M. Rolke Vice President-Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
LA JOLLA PHARMACEUTICA..0.00%338
AMGEN, INC.-13.02%105 034
GILEAD SCIENCES, INC.-28.08%95 884
CELGENE CORPORATION-5.93%87 334
REGENERON PHARMACEUTIC..-33.32%38 181
ACTELION LTD45.20%22 191
More Results